Mark Connor Selected Research

Mark Connor Research Topics

Disease

8	Pain (Aches) 01/2022 - 03/2002
7	Hypothermia 01/2022 - 08/2015
6	Inflammation (Inflammations) 12/2019 - 03/2002
4	Chronic Pain 01/2022 - 04/2005
3	Pica (Geophagia) 11/2020 - 10/2017
3	Bradycardia 10/2017 - 09/2015
2	Neuroinflammatory Diseases 01/2023 - 01/2019
2	Epilepsy (Aura) 01/2022 - 01/2022
2	Substance-Related Disorders (Drug Abuse) 01/2021 - 05/2015
2	Migraine Disorders (Migraine) 01/2019 - 11/2008
2	Glioma (Gliomas) 04/2009 - 07/2003
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2023
1	Mental Disorders (Mental Disorder) 01/2023
1	Absence Epilepsy (Childhood Absence Epilepsy) 01/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Neoplasms (Cancer) 01/2021
1	Seizures (Absence Seizure) 01/2021
1	Neuralgia (Stump Neuralgia) 01/2021
1	Constipation 01/2020
1	Anorexia Nervosa 01/2019
1	Multiple Sclerosis 01/2019
1	Nausea 01/2019
1	Vomiting 01/2019
1	Tourette Syndrome (Tourette's Syndrome) 01/2019
1	Headache (Headaches) 09/2012
1	Gout 01/2009
1	Myalgia 10/2005
1	Arthritis (Polyarthritis) 04/2005
1	Neuroblastoma 07/2003

Drug/Important Bio-Agent (IBA)

4	Opioid Analgesics (Opioids)IBA 01/2021 - 11/2008
3	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2023 - 11/2020
3	Analgesics (Analgesic Drugs)IBA 01/2022 - 11/2008
3	CannabinoidsIBA 11/2020 - 10/2017
2	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2022 - 01/2022
2	Opioid Receptors (Opioid Receptor)IBA 01/2021 - 01/2020
2	LigandsIBA 01/2020 - 11/2008
2	GTP-Binding Proteins (G-Protein)IBA 01/2020 - 09/2012
2	CB2 Cannabinoid ReceptorIBA 12/2019 - 01/2019
2	cumyl-PINACAIBA 02/2019 - 10/2017
1	Psilocybin (Psilocibin)IBA 01/2023
1	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/2023
1	Dronabinol (THC)FDA LinkGeneric 01/2022
1	Tapentadol FDA Link 01/2022
1	Therapeutic UsesIBA 01/2022
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2022
1	Morphine (MS Contin)FDA LinkGeneric 01/2022
1	Oxycodone (Oxycontin)FDA LinkGeneric 01/2022
1	Illicit Drugs (Recreational Drugs)IBA 01/2022
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2021
1	Pregabalin (Lyrica)FDA Link 01/2021
1	EpitopesIBA 01/2021
1	Cannabinoid Receptor AgonistsIBA 01/2021
1	5F-CUMYL-PICAIBA 11/2020
1	5F-CUMYL-P7AICAIBA 02/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Tryptamines (Triptans)IBA 01/2019
1	methyl (1- (5- fluoropentyl)- 1H- indazole- 3- carbonyl)valinateIBA 01/2016
1	N- (1- amino- 3- methyl- 1- oxobutan- 2- yl)- 1- pentyl- 1H- indazole- 3- carboxamideIBA 09/2015
1	AB-FUBINACAIBA 09/2015
1	1-pentyl-3-(1-naphthoyl)indoleIBA 08/2015
1	terameprocolIBA 12/2014
1	AcetoneIBA 12/2014
1	TRPA1 Cation ChannelIBA 01/2014
1	CationsIBA 01/2014
1	Serotonin (5 Hydroxytryptamine)IBA 09/2012
1	Serotonin ReceptorsIBA 09/2012
1	N'- ((E)- (2- hydroxynaphthalen- 1- yl)methylidene)- 3- (2- methyl- 1H- benzimidazol- 1- yl)propanehydrazideIBA 04/2009
1	mu Opioid Receptors (mu Opioid Receptor)IBA 04/2009
1	Uric Acid (Urate)IBA 01/2009
1	Xanthine OxidaseIBA 01/2009
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2009
1	HypoxanthineIBA 01/2009
1	EnzymesIBA 01/2009
1	Allopurinol (Remid)FDA LinkGeneric 01/2009
1	Adenosine (Adenocard)FDA LinkGeneric 01/2009
1	Sumatriptan (Imigran)FDA LinkGeneric 11/2008
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2006
1	Ion Channels (Ion Channel)IBA 10/2005
1	Bradykinin B1 ReceptorIBA 04/2005
1	Bradykinin Receptors (Bradykinin Receptor)IBA 04/2005
1	Calcium Channels (Calcium Channel)IBA 07/2003
1	gamma-Aminobutyric Acid (GABA)IBA 07/2003
1	CalciumIBA 07/2003
1	calycanthineIBA 07/2003
1	ProstaglandinsIBA 03/2002

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2019 - 11/2008
2	Induced Hypothermia 10/2017 - 09/2015
1	Therapeutics 05/2015